Even as companies tip-toe back to full operations again, the threat of a second wave of Covid-19 spread remains high. Boards must use this window to make changes, in case the impact of the second wave is higher than the first.
Boards must prepare for when things begin returning to normal again. How a company bounces back from this devastation could determine its survival.
In the fallout of COVID-19, technology has become the one sector that has uniquely benefited from the isolated workforce and the need for novel medicine. But the reliance on tech, medical technology and biotechnology in this uncertain time has provided opportunities for non-tech firms to unite with tech and medical leaders as well.
The COVID-19 crisis left organizations in a tough spot. How boards reacted in the face of this pressure may leave them liable, according to recent situations with similar outbreaks and illnesses.
In the U.S., where health insurance through an employer is the primary way to receive care, many patients may abstain from going to the doctor due to costs. This has the potential to further the spread of the virus and has put insurers in the spotlight.
The cost of epidemics is expected to rise by $23.5 trillion over the next 30 years, as the rates of the such illnesses increase. The coronavirus has shown that such an epidemic halts business and can impact all parts of the company, from the supply chain to how employees work.
JPMorgan Chase & Co. announced that Chairman and CEO Jamie Dimon had to undergo emergency heart surgery. An emergency medical situation – or worse – impacting the person in the CEO role can forever damage a company, a scare that no board wants to deal with. But they can prepare, just in case.
The New York Times has reported that executives at Walgreens Boots Alliance asked consultants to remove findings from an internal report that included complaints from its employees. For a better way of making sure information isn’t hidden from the board, look towards this technology darling.
Global manufacturing is expected to feel the impact of the spread of the coronavirus — not the least because China is a far larger exporter than it was during the 2003 SARS virus outbreak, according to The Wall Street Journal.
Earlier this year, automotive giant Volkswagen found itself facing a regulatory investigation for the results of their diesel-emissions tests. For some, the ensuing negative headlines would have broken the company. Not so for VW, which has embraced the opportunity to learn from the experience, protect shareholder value and position itself for even better days. Recorded at DirectorCorps’ Avoiding the Corporate Crisis Conference on December 3, 2019 at the Nasdaq MarketSite in NYC.